The Centers for Disease Control and Prevention changed course Tuesday on some masking guidelines, recommending that even vaccinated people return to wearing masks indoors in parts of the U.S. where the delta variant of the ...
Jul 27, 2021
0
5
Infections are climbing across the U.S., and mask mandates and other COVID-19 prevention measures are making a comeback in some places as health officials issue increasingly dire warnings about the highly contagious delta ...
Jul 26, 2021
0
2
Lagging vaccination rates among nursing home staff are being linked to a national increase in COVID-19 infections and deaths at senior facilities, and are at the center of a federal investigation in a hard-hit Colorado location ...
Jul 22, 2021
0
6
Canada announced Monday it will begin letting fully vaccinated U.S. citizens into Canada on Aug. 9, and those from the rest of the world on Sept. 7.
Jul 19, 2021
0
0
New Zealanders' intention to get a COVID-19 vaccine is at its highest since last year, at 81% of the adult population, according to our latest research.
Jul 14, 2021
0
2
Hospitals and other health care facilities should require their employees to be vaccinated against COVID-19, a coalition of seven organizations representing medical professionals said Tuesday.
Jul 14, 2021
0
2
The COVID-19 curve in the U.S. is rising again after months of decline, with the number of new cases per day doubling over the past three weeks, driven by the fast-spreading delta variant, lagging vaccination rates and Fourth ...
Jul 13, 2021
0
3
Throughout the pandemic, we have been checking in with Dr. Howard Forman, a public authority on COVID-19 and healthcare policy, to get his take on the fight against the virus. Nationally, infection rates are close to their ...
Jul 12, 2021
0
2
A vaccine to protect against infection with hepatitis C could be in use within 5 years, says Professor Sir Michael Houghton, who won the Nobel Prize for Medicine and Physiology along with three other scientists for discovering ...
Jul 12, 2021
0
11
Interim data from a phase 3 trial of a COVID-19 vaccine developed in China (CoronaVac) suggests that two doses offer 83.5% protection against symptomatic COVID-19.
Jul 9, 2021
0
4
